MSI Methylation Sciences is a biotechnology company focused on the central nervous system (CNS) area. Its product candidate, Strada, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Strada can be used for the treatment of major depressive disorder (MDD).